How to assess drug efficacy in osteoporosis-Reference-Cited by-同舟云学术

How to assess drug efficacy in osteoporosis

Published:1995-03 Issue:8952 Volume:345 Page:743-744
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cooper Cyrus,Kanis JohnA.,Compston Juliet

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. Epidemiology of osteoporosis;Cooper;Trends Endocrinol Metab,1992

2. Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis;US Food and Drug Administration,1994

3. The assessment of vertebral deformity: a method for use in population studies and clinical trials;McCloskey;Osteoporosis Int,1993

4. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989;Cooper;J Bone Min Res,1992

5. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis;Study Group;WHO Tech Report Series,1994

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases;Arthritis & Rheumatism;2005

2. Etidronate and Alendronate in the Treatment of Postmenopausal Osteoporosis;Annals of Pharmacotherapy;1999-05

3. Should we look for osteoporosis in patients with rheumatoid arthritis?;Annals of the Rheumatic Diseases;1998-06-01

4. The Effectiveness of Bone Density Measurement and Associated Treatments for Prevention of Fractures:An International Collaborative Review;International Journal of Technology Assessment in Health Care;1998

5. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995;Climacteric;1998-01